nodes	percent_of_prediction	percent_of_DWPC	metapath
SIMEPREVIR—CYP1A2—Progesterone—uterine cancer	0.146	0.186	CbGbCtD
SIMEPREVIR—ABCB1—Progesterone—uterine cancer	0.128	0.162	CbGbCtD
SIMEPREVIR—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.116	0.147	CbGbCtD
SIMEPREVIR—ABCB1—Dactinomycin—uterine cancer	0.102	0.129	CbGbCtD
SIMEPREVIR—CYP3A4—Progesterone—uterine cancer	0.0767	0.0973	CbGbCtD
SIMEPREVIR—CYP1A2—Etoposide—uterine cancer	0.0656	0.0831	CbGbCtD
SIMEPREVIR—ABCB1—Etoposide—uterine cancer	0.0573	0.0727	CbGbCtD
SIMEPREVIR—ABCB1—Doxorubicin—uterine cancer	0.0391	0.0496	CbGbCtD
SIMEPREVIR—CYP3A4—Etoposide—uterine cancer	0.0343	0.0436	CbGbCtD
SIMEPREVIR—CYP3A4—Doxorubicin—uterine cancer	0.0234	0.0297	CbGbCtD
SIMEPREVIR—CTSS—exocrine gland—uterine cancer	0.0161	0.14	CbGeAlD
SIMEPREVIR—CTSS—myometrium—uterine cancer	0.00891	0.0778	CbGeAlD
SIMEPREVIR—CTSS—uterine cervix—uterine cancer	0.00693	0.0606	CbGeAlD
SIMEPREVIR—CTSS—smooth muscle tissue—uterine cancer	0.00674	0.0589	CbGeAlD
SIMEPREVIR—CTSS—decidua—uterine cancer	0.0066	0.0577	CbGeAlD
SIMEPREVIR—CTSS—renal system—uterine cancer	0.00648	0.0567	CbGeAlD
SIMEPREVIR—CTSS—endometrium—uterine cancer	0.00627	0.0548	CbGeAlD
SIMEPREVIR—CTSS—mammalian vulva—uterine cancer	0.00606	0.053	CbGeAlD
SIMEPREVIR—CTSS—uterus—uterine cancer	0.00578	0.0505	CbGeAlD
SIMEPREVIR—CTSS—female reproductive system—uterine cancer	0.00519	0.0454	CbGeAlD
SIMEPREVIR—CTSS—female gonad—uterine cancer	0.00473	0.0413	CbGeAlD
SIMEPREVIR—CTSS—vagina—uterine cancer	0.0047	0.041	CbGeAlD
SIMEPREVIR—SLCO1B1—renal system—uterine cancer	0.0042	0.0367	CbGeAlD
SIMEPREVIR—SLCO1B1—female reproductive system—uterine cancer	0.00336	0.0294	CbGeAlD
SIMEPREVIR—CTSS—lymph node—uterine cancer	0.00304	0.0265	CbGeAlD
SIMEPREVIR—Infection—Carboplatin—uterine cancer	0.00298	0.0307	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Progesterone—uterine cancer	0.00234	0.0241	CcSEcCtD
SIMEPREVIR—CYP1A2—renal system—uterine cancer	0.00223	0.0195	CbGeAlD
SIMEPREVIR—Hepatobiliary disease—Medroxyprogesterone Acetate—uterine cancer	0.00212	0.0218	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Progesterone—uterine cancer	0.002	0.0206	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00181	0.0186	CcSEcCtD
SIMEPREVIR—Anaemia—Progesterone—uterine cancer	0.00178	0.0184	CcSEcCtD
SIMEPREVIR—Myalgia—Progesterone—uterine cancer	0.00164	0.0169	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00163	0.0168	CcSEcCtD
SIMEPREVIR—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00162	0.0166	CcSEcCtD
SIMEPREVIR—CYP3A4—renal system—uterine cancer	0.00162	0.0141	CbGeAlD
SIMEPREVIR—ALB—lymph node—uterine cancer	0.00159	0.0139	CbGeAlD
SIMEPREVIR—ABCB1—myometrium—uterine cancer	0.00157	0.0137	CbGeAlD
SIMEPREVIR—Infection—Progesterone—uterine cancer	0.00157	0.0161	CcSEcCtD
SIMEPREVIR—Skin disorder—Progesterone—uterine cancer	0.00153	0.0158	CcSEcCtD
SIMEPREVIR—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.00149	0.0153	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.0152	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00144	0.0148	CcSEcCtD
SIMEPREVIR—Insomnia—Progesterone—uterine cancer	0.00143	0.0147	CcSEcCtD
SIMEPREVIR—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.0146	CcSEcCtD
SIMEPREVIR—Dyspnoea—Progesterone—uterine cancer	0.0014	0.0145	CcSEcCtD
SIMEPREVIR—Hyperbilirubinaemia—Epirubicin—uterine cancer	0.00139	0.0143	CcSEcCtD
SIMEPREVIR—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00139	0.0143	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Progesterone—uterine cancer	0.00136	0.014	CcSEcCtD
SIMEPREVIR—Fatigue—Progesterone—uterine cancer	0.00136	0.014	CcSEcCtD
SIMEPREVIR—Constipation—Progesterone—uterine cancer	0.00135	0.0139	CcSEcCtD
SIMEPREVIR—Blood bilirubin increased—Epirubicin—uterine cancer	0.00134	0.0138	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.0013	0.0134	CcSEcCtD
SIMEPREVIR—CYP3A4—female reproductive system—uterine cancer	0.00129	0.0113	CbGeAlD
SIMEPREVIR—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00129	0.0133	CcSEcCtD
SIMEPREVIR—Hyperbilirubinaemia—Doxorubicin—uterine cancer	0.00129	0.0133	CcSEcCtD
SIMEPREVIR—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00127	0.0131	CcSEcCtD
SIMEPREVIR—Anaemia—Dactinomycin—uterine cancer	0.00126	0.013	CcSEcCtD
SIMEPREVIR—Blood bilirubin increased—Doxorubicin—uterine cancer	0.00124	0.0128	CcSEcCtD
SIMEPREVIR—ABCB1—epithelium—uterine cancer	0.00123	0.0108	CbGeAlD
SIMEPREVIR—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00123	0.0127	CcSEcCtD
SIMEPREVIR—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00123	0.0127	CcSEcCtD
SIMEPREVIR—ABCB1—uterine cervix—uterine cancer	0.00122	0.0107	CbGeAlD
SIMEPREVIR—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00122	0.0126	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Etoposide—uterine cancer	0.0012	0.0123	CcSEcCtD
SIMEPREVIR—ABCB1—decidua—uterine cancer	0.00116	0.0102	CbGeAlD
SIMEPREVIR—Myalgia—Dactinomycin—uterine cancer	0.00116	0.012	CcSEcCtD
SIMEPREVIR—ABCB1—renal system—uterine cancer	0.00114	0.01	CbGeAlD
SIMEPREVIR—Asthenia—Progesterone—uterine cancer	0.00113	0.0116	CcSEcCtD
SIMEPREVIR—Pruritus—Progesterone—uterine cancer	0.00111	0.0115	CcSEcCtD
SIMEPREVIR—Infection—Dactinomycin—uterine cancer	0.00111	0.0114	CcSEcCtD
SIMEPREVIR—ABCB1—endometrium—uterine cancer	0.00111	0.00966	CbGeAlD
SIMEPREVIR—ABCB1—mammalian vulva—uterine cancer	0.00107	0.00935	CbGeAlD
SIMEPREVIR—Photosensitivity—Epirubicin—uterine cancer	0.00105	0.0108	CcSEcCtD
SIMEPREVIR—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.0105	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Etoposide—uterine cancer	0.00102	0.0105	CcSEcCtD
SIMEPREVIR—ABCB1—uterus—uterine cancer	0.00102	0.00891	CbGeAlD
SIMEPREVIR—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00101	0.0104	CcSEcCtD
SIMEPREVIR—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00101	0.0104	CcSEcCtD
SIMEPREVIR—Rash—Progesterone—uterine cancer	0.000993	0.0102	CcSEcCtD
SIMEPREVIR—Dermatitis—Progesterone—uterine cancer	0.000993	0.0102	CcSEcCtD
SIMEPREVIR—Headache—Progesterone—uterine cancer	0.000987	0.0102	CcSEcCtD
SIMEPREVIR—Photosensitivity—Doxorubicin—uterine cancer	0.000969	0.00997	CcSEcCtD
SIMEPREVIR—Fatigue—Dactinomycin—uterine cancer	0.00096	0.00989	CcSEcCtD
SIMEPREVIR—Nausea—Progesterone—uterine cancer	0.000936	0.00964	CcSEcCtD
SIMEPREVIR—ABCB1—female reproductive system—uterine cancer	0.000916	0.00801	CbGeAlD
SIMEPREVIR—Anaemia—Etoposide—uterine cancer	0.000913	0.0094	CcSEcCtD
SIMEPREVIR—Rash—Medroxyprogesterone Acetate—uterine cancer	0.0009	0.00927	CcSEcCtD
SIMEPREVIR—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000899	0.00926	CcSEcCtD
SIMEPREVIR—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000894	0.00921	CcSEcCtD
SIMEPREVIR—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000848	0.00873	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000835	0.0086	CcSEcCtD
SIMEPREVIR—ABCB1—female gonad—uterine cancer	0.000834	0.00728	CbGeAlD
SIMEPREVIR—ABCB1—vagina—uterine cancer	0.000829	0.00724	CbGeAlD
SIMEPREVIR—Infection—Etoposide—uterine cancer	0.000801	0.00824	CcSEcCtD
SIMEPREVIR—Asthenia—Dactinomycin—uterine cancer	0.000799	0.00823	CcSEcCtD
SIMEPREVIR—Skin disorder—Etoposide—uterine cancer	0.000783	0.00806	CcSEcCtD
SIMEPREVIR—Photosensitivity reaction—Epirubicin—uterine cancer	0.000725	0.00747	CcSEcCtD
SIMEPREVIR—Dyspnoea—Etoposide—uterine cancer	0.000719	0.0074	CcSEcCtD
SIMEPREVIR—Rash—Dactinomycin—uterine cancer	0.000702	0.00723	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Etoposide—uterine cancer	0.000696	0.00716	CcSEcCtD
SIMEPREVIR—Fatigue—Etoposide—uterine cancer	0.000695	0.00715	CcSEcCtD
SIMEPREVIR—Constipation—Etoposide—uterine cancer	0.000689	0.0071	CcSEcCtD
SIMEPREVIR—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000671	0.00691	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Epirubicin—uterine cancer	0.00067	0.0069	CcSEcCtD
SIMEPREVIR—Nausea—Dactinomycin—uterine cancer	0.000661	0.00681	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Doxorubicin—uterine cancer	0.00062	0.00638	CcSEcCtD
SIMEPREVIR—Asthenia—Etoposide—uterine cancer	0.000578	0.00595	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Epirubicin—uterine cancer	0.000573	0.0059	CcSEcCtD
SIMEPREVIR—Pruritus—Etoposide—uterine cancer	0.00057	0.00587	CcSEcCtD
SIMEPREVIR—ABCB1—lymph node—uterine cancer	0.000536	0.00468	CbGeAlD
SIMEPREVIR—Mediastinal disorder—Doxorubicin—uterine cancer	0.00053	0.00546	CcSEcCtD
SIMEPREVIR—Anaemia—Epirubicin—uterine cancer	0.000512	0.00527	CcSEcCtD
SIMEPREVIR—Rash—Etoposide—uterine cancer	0.000508	0.00523	CcSEcCtD
SIMEPREVIR—Dermatitis—Etoposide—uterine cancer	0.000508	0.00523	CcSEcCtD
SIMEPREVIR—Headache—Etoposide—uterine cancer	0.000505	0.0052	CcSEcCtD
SIMEPREVIR—Nausea—Etoposide—uterine cancer	0.000479	0.00493	CcSEcCtD
SIMEPREVIR—Anaemia—Doxorubicin—uterine cancer	0.000473	0.00487	CcSEcCtD
SIMEPREVIR—Myalgia—Epirubicin—uterine cancer	0.000471	0.00485	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000468	0.00482	CcSEcCtD
SIMEPREVIR—Infection—Epirubicin—uterine cancer	0.000449	0.00462	CcSEcCtD
SIMEPREVIR—Skin disorder—Epirubicin—uterine cancer	0.000439	0.00452	CcSEcCtD
SIMEPREVIR—Myalgia—Doxorubicin—uterine cancer	0.000436	0.00449	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000433	0.00446	CcSEcCtD
SIMEPREVIR—Infection—Doxorubicin—uterine cancer	0.000415	0.00428	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000412	0.00424	CcSEcCtD
SIMEPREVIR—Insomnia—Epirubicin—uterine cancer	0.000409	0.00421	CcSEcCtD
SIMEPREVIR—Skin disorder—Doxorubicin—uterine cancer	0.000406	0.00418	CcSEcCtD
SIMEPREVIR—Dyspnoea—Epirubicin—uterine cancer	0.000403	0.00415	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Epirubicin—uterine cancer	0.00039	0.00402	CcSEcCtD
SIMEPREVIR—Fatigue—Epirubicin—uterine cancer	0.00039	0.00401	CcSEcCtD
SIMEPREVIR—Constipation—Epirubicin—uterine cancer	0.000386	0.00398	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000381	0.00392	CcSEcCtD
SIMEPREVIR—Insomnia—Doxorubicin—uterine cancer	0.000378	0.00389	CcSEcCtD
SIMEPREVIR—Dyspnoea—Doxorubicin—uterine cancer	0.000373	0.00384	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000361	0.00372	CcSEcCtD
SIMEPREVIR—Fatigue—Doxorubicin—uterine cancer	0.00036	0.00371	CcSEcCtD
SIMEPREVIR—Constipation—Doxorubicin—uterine cancer	0.000357	0.00368	CcSEcCtD
SIMEPREVIR—Asthenia—Epirubicin—uterine cancer	0.000324	0.00334	CcSEcCtD
SIMEPREVIR—Pruritus—Epirubicin—uterine cancer	0.00032	0.00329	CcSEcCtD
SIMEPREVIR—Asthenia—Doxorubicin—uterine cancer	0.0003	0.00309	CcSEcCtD
SIMEPREVIR—Pruritus—Doxorubicin—uterine cancer	0.000296	0.00305	CcSEcCtD
SIMEPREVIR—Rash—Epirubicin—uterine cancer	0.000285	0.00293	CcSEcCtD
SIMEPREVIR—Dermatitis—Epirubicin—uterine cancer	0.000285	0.00293	CcSEcCtD
SIMEPREVIR—Headache—Epirubicin—uterine cancer	0.000283	0.00291	CcSEcCtD
SIMEPREVIR—Nausea—Epirubicin—uterine cancer	0.000268	0.00276	CcSEcCtD
SIMEPREVIR—Rash—Doxorubicin—uterine cancer	0.000264	0.00271	CcSEcCtD
SIMEPREVIR—Dermatitis—Doxorubicin—uterine cancer	0.000263	0.00271	CcSEcCtD
SIMEPREVIR—Headache—Doxorubicin—uterine cancer	0.000262	0.0027	CcSEcCtD
SIMEPREVIR—Nausea—Doxorubicin—uterine cancer	0.000248	0.00256	CcSEcCtD
